InvestorsHub Logo
Followers 7
Posts 292
Boards Moderated 0
Alias Born 08/03/2020

Re: tryn2 post# 36371

Tuesday, 02/23/2021 1:44:35 PM

Tuesday, February 23, 2021 1:44:35 PM

Post# of 44690
Relief and NeuroRX are in a partnership. NeuroRX is the company running the trial and therefore reports most of the news and explains how the trial is going etc (Javitt is the CEO). Relief holds the patent for Zyesami/Aviptadil. This board often speaks as if Javitt works for Relief because for better or worse he is the defacto face for both companies.